CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 14 filers reported holding CYCLO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,478 | -3.3% | 282,027 | +8.3% | 0.00% | – |
| Q2 2023 | $413,999 | +94.1% | 260,377 | +2.6% | 0.00% | – |
| Q1 2023 | $213,286 | -40.8% | 253,882 | 0.0% | 0.00% | – |
| Q4 2022 | $360,512 | -26.4% | 253,882 | +0.0% | 0.00% | – |
| Q3 2022 | $490,000 | -2.0% | 253,765 | 0.0% | 0.00% | – |
| Q2 2022 | $500,000 | -38.1% | 253,765 | -0.5% | 0.00% | – |
| Q1 2022 | $808,000 | -14.8% | 255,065 | +0.3% | 0.00% | – |
| Q4 2021 | $948,000 | -18.2% | 254,301 | +48.1% | 0.00% | – |
| Q3 2021 | $1,159,000 | -25.2% | 171,681 | +13.3% | 0.00% | – |
| Q2 2021 | $1,550,000 | +461.6% | 151,540 | +350.4% | 0.00% | – |
| Q1 2021 | $276,000 | – | 33,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 75,787 | $240,000 | 0.00% |
| ROYAL BANK OF CANADA | 746 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 255,065 | $808,000 | 0.00% |
| UBS Group AG | 2,291 | $7,000 | 0.00% |
| IFP Advisors, Inc | 26 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,047 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,316 | $153,000 | 0.00% |
| STATE STREET CORP | 28,300 | $90,000 | 0.00% |
| CITIGROUP INC | 1,232 | $4,000 | 0.00% |